Corrigendum to “Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera” [Leuk. Res. Rep. 3 (2) (2014) 73–75]

Podobne zapisy

• Corrigendum to “Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera” [Leuk. Res. Rep. 3 (2) (2014) 73–75]
  od: M.E. Bjørn, i wsp.
  Wydane: (2015-01-01)
• Combination therapy with interferon and JAK1-2 inhibitor is feasible: Proof of concept with rapid reduction in JAK2V617F-allele burden in polycythemia vera
  od: Bjørn, M.E., i wsp.
  Wydane: (2014)
• JAK2 V617F and the evolving paradigm of polycythemia vera
  od: Means, Robert T.
  Wydane: (2010)
• Coexistence of gain-of-function JAK2 germ line mutations with JAK2(V617F) in polycythemia vera
  od: Lanikova, Lucie, i wsp.
  Wydane: (2016)
• JAK2 Negative Polycythemia Vera
  od: Geetha, J P, i wsp.
  Wydane: (2010)